Chemoinformaics analysis of Z-(13,14-EPOXY)TETRADEC-11-EN-1-OL ACETATE
| Molecular Weight | 268.397 | nRot | 12 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 5 |
| Exact Molecular Weight | 268.204 | nRing | 1 |
| Solubility: LogS | -3.824 | nHRing | 1 |
| Solubility: LogP | 4.781 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 47.7962 |
| nHD | 0 | BPOL | 32.4298 |
| QED | 0.232 |
| Synth | 2.878 |
| Natural Product Likeliness | 1.347 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.698 |
| MDCK | 0.000032 |
| BBB | 0.428 |
| PPB | 0.946823 |
| VDSS | 1.367 |
| FU | 0.0533863 |
| CYP1A2-inh | 0.831 |
| CYP1A2-sub | 0.348 |
| CYP2c19-inh | 0.595 |
| CYP2c19-sub | 0.083 |
| CYP2c9-inh | 0.389 |
| CYP2c9-sub | 0.337 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.361 |
| CYP3a4-sub | 0.131 |
| CL | 3.008 |
| T12 | 0.305 |
| hERG | 0.034 |
| Ames | 0.307 |
| ROA | 0.046 |
| SkinSen | 0.949 |
| Carcinogencity | 0.333 |
| EI | 0.979 |
| Respiratory | 0.19 |
| NR-Aromatase | 0.867 |
| Antiviral | Yes |
| Prediction | 0.697822 |